首页> 外文期刊>Cancer discovery. >Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma
【24h】

Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma

机译:MYB和MYBL1中的复发性融合在涎腺腺样囊性癌中定义了一个常见的转录因子驱动的致癌途径。

获取原文
获取原文并翻译 | 示例
       

摘要

Adenoid cystic carcinoma (ACC), the second most common malignancy of salivary glands, is a rare tumor with a bleak prognosis for which therapeutic targets are unavailable. We used RNA sequencing (RNA-seq) to analyze low-quality RNA from archival, formaldehyde-fixed, paraffin-embedded samples. In addition to detecting the most common ACC translocation, t(6;9) fusing the MYB proto-oncogene to NFIB, we also detected previously unknown t(8; 9) and t(8; 14) translocations fusing the MYBL1 gene to the NFIB and RAD51B genes, respectively. RNA-seq provided information about gene fusions, alternative RNA splicing, and gene expression signatures. Interestingly, tumors with MYB and MYBL1 translocations displayed similar gene expression profiles, and the combined MYB and MYBL1 expression correlated with outcome, suggesting that the related MYB proteins are interchangeable oncogenic drivers in ACC. Our results provide important details about the biology of ACC and illustrate how archival tissue samples can be used for detailed molecular analyses of rare tumors.
机译:涎腺第二大最常见的恶性腺样囊性癌(ACC)是一种罕见的肿瘤,预后不佳,尚无治疗靶点。我们使用RNA测序(RNA-seq)分析来自存档,甲醛固定,石蜡包埋样品的低质量RNA。除了检测最常见的ACC易位t(6; 9)将MYB原癌基因融合到NFIB外,我们还检测了以前未知的t(8; 9)和t(8; 14)易位将MYBL1基因融合到NFIB。分别为NFIB和RAD51B基因。 RNA-seq提供有关基因融合,RNA选择性剪接和基因表达特征的信息。有趣的是,具有MYB和MYBL1易位的肿瘤表现出相似的基因表达谱,并且结合的MYB和MYBL1表达与结局相关,表明相关的MYB蛋白是ACC中可互换的致癌驱动因子。我们的结果提供了有关ACC生物学的重要细节,并说明了档案组织样品如何用于稀有肿瘤的详细分子分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号